Agenus Set To Create Asset Token For New BioTech Industry Drugs
The National Cancer Institute claims there were an estimated 1,735,350 new cases of cancer diagnosed last year in the US. In the race to cure and stop cancer from devastating more lives, Agenus has launched the first asset-backed digital security.
The digital security will allow for a faster financing vehicle and help more targeted investments by qualified investors in the development of therapeutic products.
